{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:04:03Z","timestamp":1792281843698,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.urolonc.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T09:02:47Z","timestamp":1371114167000},"page":"38.e9-38.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Utility of [11C]choline PET\/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series"],"prefix":"10.1016","volume":"32","author":[{"given":"Niccol\u00f2 M.","family":"Passoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Giovacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2013.03.006_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Cancer of the Prostate Strategic Urological Research E. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2013.03.006_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","article-title":"Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience","volume":"28","author":"Han","year":"2001","journal-title":"Urol Clin North Am"},{"issue":"3","key":"10.1016\/j.urolonc.2013.03.006_bib3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.03.006_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/01.ju.0000091876.13656.2e","article-title":"The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy","volume":"170","author":"Ward","year":"2003","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2013.03.006_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.6004\/jnccn.2012.0114","article-title":"Prostate cancer, Version 3.2012 featured updates to the NCCN guidelines","volume":"10","author":"Mohler","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.urolonc.2013.03.006_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":"EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2013.03.006_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2013.03.006_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(96)00161-6","article-title":"Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy","volume":"48","author":"Flanigan","year":"1996","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2013.03.006_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.urolonc.2013.03.006_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eururo.2006.10.045","article-title":"The natural history of noncastrate metastatic prostate cancer after radical prostatectomy","volume":"51","author":"Yossepowitch","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2013.03.006_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2010.11.031","article-title":"Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer","volume":"82","author":"Jereczek-Fossa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2013.03.006_bib12","article-title":"Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer","author":"Jereczek-Fossa","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.03.006_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","article-title":"Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography","volume":"60","author":"Rigatti","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2013.03.006_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2007.03.032","article-title":"Detection of lymph-node metastases with integrated [11C]choline PET\/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy","volume":"52","author":"Scattoni","year":"2007","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.03.006_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.eururo.2012.08.003","article-title":"18F-fluoroethylcholine PET\/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent","volume":"63","author":"Tilki","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2013.03.006_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1464-410X.2008.07592.x","article-title":"Histological verification of 11C-choline-positron emission\/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer","volume":"102","author":"Schilling","year":"2008","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.urolonc.2013.03.006_bib17","first-page":"331","article-title":"Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET","volume":"44","author":"de Jong","year":"2003","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.urolonc.2013.03.006_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"issue":"4 Pt 1","key":"10.1016\/j.urolonc.2013.03.006_bib19","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/01.ju.0000137817.56888.d1","article-title":"Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping","volume":"172","author":"Bochner","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.03.006_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)37720-0","article-title":"Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging","volume":"146","author":"McSherry","year":"1991","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.03.006_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eururo.2010.09.004","article-title":"The role of choline positron emission tomography\/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer","volume":"59","author":"Picchio","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2013.03.006_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00259-010-1403-7","article-title":"PSA doubling time for prediction of [(11)C]choline PET\/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.urolonc.2013.03.006_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of [11C]choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.urolonc.2013.03.006_bib24","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.urolonc.2013.03.006_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2006.09.008","article-title":"Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy","volume":"69","author":"Briganti","year":"2007","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913001713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913001713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:03:03Z","timestamp":1761040983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913001713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1078143913001713"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.03.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of [11C]choline PET\/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}